Steven R. Feldman, MD, PhD

Article

Clinical Outcomes of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Based on Hospital Admission Type

Author:: Steven R. Feldman, MD, PhD

Publish date: August 1, 2025

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, life-threatening conditions that involve widespread necrosis of the s...

Article

Optimal Exercise Levels for Dermatology Patients With Psoriasis

Author:: Steven R. Feldman, MD, PhD

Publish date: December 17, 2024

There is a direct link between psoriasis and metabolic conditions such as diabetes mellitus and obesity.¹

Article

Utilization, Cost, and Prescription Trends of Antipsychotics Prescribed by Dermatologists for Medicare Patients

Author:: Steven R. Feldman, MD, PhD

Publish date: October 11, 2024

To the Editor:

Patients with primary psychiatric disorders with dermatologic manifestations often seek treatment from dermatologists instead...

Article

Commentary: Topical Treatments for AD and Possible Lifestyle Adjustments, July 2024

Author:: Steven R. Feldman, MD, PhD

Publish date: June 28, 2024

Article

Commentary: Interrelationships Between AD and Other Conditions, June 2024

Author:: Steven R. Feldman, MD, PhD

Publish date: May 16, 2024

Article

Commentary: Studies Often Do Not Answer Clinical Questions in AD, May 2024

Author:: Steven R. Feldman, MD, PhD

Publish date: April 25, 2024

Article

Commentary: Choosing Treatments of AD, and Possible Connection to Learning Issues, April 2024

Author:: Steven R. Feldman, MD, PhD

Publish date: March 26, 2024

Article

Commentary: Drug Comparisons and Contact Allergy in AD, February 2024

Author:: Steven R. Feldman, MD, PhD

Publish date: January 24, 2024

Article

Commentary: JAK Inhibitors and Comorbidities in AD, December 2023

Author:: Steven R. Feldman, MD, PhD

Publish date: November 21, 2023

Article

Commentary: New and old treatments for AD, November 2023

Author:: Steven R. Feldman, MD, PhD

Publish date: October 31, 2023

Article

Concurrent Atopic Dermatitis and Psoriasis Successfully Treated With Dual Biologic Therapy

Author:: Steven R. Feldman, MD, PhD

Publish date: September 21, 2023

Atopic dermatitis and psoriasis can coexist in a single patient, which may be suspected from a clinical picture of treatment-resistant disease, a p...

Article

Commentary: Are "significant" results necessarily clinically meaningful? October 2023

Author:: Steven R. Feldman, MD, PhD

Publish date: September 20, 2023

Article

Commentary: Newer Drugs for AD Plus Dupilumab and Other Issues, September 2023

Author:: Steven R. Feldman, MD, PhD

Publish date: August 24, 2023

Article

Commentary: Abrocitinib, Malignancy Risk, and S aureus in AD, August 2023

Author:: Steven R. Feldman, MD, PhD

Publish date: July 31, 2023

Article

Commentary: Topical treatments, dupilumab, and long-term treatment of AD, July 2023

Author:: Steven R. Feldman, MD, PhD

Publish date: June 22, 2023